Back to Search
Start Over
<scp>MGMT</scp> inactivation as a new biomarker in patients with advanced biliary tract cancers
- Source :
- Molecular Oncology. 16:2733-2746
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
-
Abstract
- Biliary tract cancers (BTCs) have poor prognosis and limited therapeutic options. The impact of O
- Subjects :
- Cancer Research
Settore MED/06 - Oncologia Medica
MGMT
biliary tract cancer
biomarker
cholangiocarcinoma
molecular profiling
temozolomide
Biomarkers
DNA Modification Methylases
DNA Repair Enzymes
Humans
O(6)-Methylguanine-DNA Methyltransferase
Precision Medicine
Tumor Suppressor Proteins
Bile Duct Neoplasms
Biliary Tract Neoplasms
General Medicine
Oncology
Genetics
Molecular Medicine
Subjects
Details
- ISSN :
- 18780261 and 15747891
- Volume :
- 16
- Database :
- OpenAIRE
- Journal :
- Molecular Oncology
- Accession number :
- edsair.doi.dedup.....f6683ca04df4012a048bd200b760b272
- Full Text :
- https://doi.org/10.1002/1878-0261.13256